Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Plos One|June 28, 2016
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective StudyEmanuele D'Amico, Carmela Leone, Giusi Graziano, et al.
Assistenza Infermieristica E Ricerca : AIR|May 11, 2007
[Epidemiology without numbers: nurses tell their perception, and the management strategies, of the behavioral problems of the elderly]Fosca Andriolo, Morgan Bertollo, Sergio Bragagnolo, et al.
Journal of Clinical Medicine|May 28, 2025
When Real-World Outcomes Do Not Meet the Results of Clinical Trials: Transfemoral Transcatheter vs. Surgical Aortic Valve Replacement in an Intermediate-Age Population (The Outstanding Italy Study)Marco Ranucci, Lidia Staszewsky, Massimo Cartabia, et al.
Plos One|November 8, 2012
Geographical variations in sex ratio trends over time in multiple sclerosisMaria Trojano, Guglielmo Lucchese, Giusi Graziano, et al.
European Journal of Heart Failure|March 1, 2018
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetesFranco Cosmi, Li Shen, Michela Magnoli, et al.
Brain : a Journal of Neurology|March 24, 2022
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort studyEmilio Portaccio, Angelo Bellinvia, Mattia Fonderico, et al.
Brain : a Journal of Neurology|September 13, 2015
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Carlo Pozzilli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 20, 2022
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control StudyPietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 7, 2024
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched studyClara G Chisari, Umberto Aguglia, Maria Pia Amato, et al.
Journal of Neurology|May 28, 2024
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progressionEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Pageof 5